Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The understanding of ...

Historically, patients diagnosed with castration-resistant prostate cancer (CRPC) have had poor survival rates. In recent years there have been significant advances in the treatment of CRPC. In ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas Barwick / Getty Images The chartered retirement planning counselor® (CRPC) ...

Feasibility of RNA sequencing to detect TMPRSS2:ERG fusions following laser capture microdissection of prostate cancer. This is an ASCO Meeting Abstract from the 2013 Genitourinary Cancers Symposium.

Castration-resistant prostate cancer (CRPC) has a poor prognosis and remains a significant therapeutic challenge. Before 2010, only docetaxel-based chemotherapy improved survival in patients with CRPC ...